Primary sarcoma of pulmonary artery and valve: Multimodality treatment by chemotherapy and homograft replacement  by Zerkowski, Hans-Reinhard et al.
1122 Brief communications 
The Journal of Thoracic and 
Cardiovascular Surgery 
October 1996 
PRIMARY SARCOMA OF PULMONARY ARTERY AND VALVE: MULTIMODALITY TREATMENT BY 
CHEMOTHERAPY AND HOMOGRAFT REPLACEMENT 
Hans-Reinhard Zerkowski, MD, a Hans-Stefan Hofmann, MD, a Iwan Gybels, MD, a and Jtirgen Knolle, MD, b 
Halle, Germany 
Primary pulmonary sarcomas are extremely rare tu- 
mors. Since the first description by Mandelstamm 1 in 
1923, only about 100 case reports have been published, 
and only a few have dealt with combined treatment of 
primary sarcoma. We report on a woman with a metas- 
tasizing pulmonary sarcoma of the pulmonary valve 
with infiltration of the pulmonary artery. After com- 
plete remission of the pulmonary metastases with poly- 
chemotherapy, the patient underwent curative resec- 
tion of the tumor and insertion of a cryopreserved 
homograft. 
A 49-year-old woman was admitted because of in- 
creasing short of breath with exercise. She had pericar- 
ditis about 6 months previously. Since then, both chest 
and back pain occurred frequently, associated with 
tachycardia nd dyspnea. Auscultation revealed a 3/6 
systolic ejection murmur in the second left intercostal 
space and a markedly split second heart sound. There 
were signs of right ventricular overload on the electro- 
cardiogram. The initial chest radiograph showed sev- 
eral bilateral pulmonary nodular lesions, confirmed by 
computed tomographic scan. Two-dimensional and 
transesophageal echocardiography revealed an en- 
larged right ventricle and an abnormal structure in the 
main and right pulmonary arteries. Right heart cathe- 
terization showed elevated right ventricular and pulmo- 
nary arterial pressures, with a ventricular-distal pulmo- 
nary artery gradient of 40 mmHg. The main and right 
pulmonary arteries were seen by cineangiography to be 
incompletely perfused. Needle biopsy was carried out 
for cytologic and histologic examination of the pulmo- 
nary nodular lesions, which we had suspected and later 
confirmed to be hemangiosarcoma. Elective resection 
of the right sided lung metastases was incomplete as a 
result of life-threatening hemodynamic nstability. His- 
tologic examination of one of these tumors revealed 
granulation and scar tissue without evidence of malig- 
nancy. 
Because of progression of right heart failure and growth 
of the pulmonary lesions seen on the computed tomo- 
graphic scan, chemotherapy was initiated. In the subse- 
quent 7 months, polychemotherapy (etoposide, vincris- 
tine, ifosfamide, adriamycin) was administered for six 
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Fig. 1. Preoperative magnetic resonance scan shows a 
mass in the pulmonary artery. 
cycles. Response was demonstrated after the second cycle. 
At the end of this treatment, magnetic resonance imaging 
revealed complete remission of all pulmonary nodules and 
reperfusion of both lungs; significant umor remained in 
the right ventricular outflow tract and the pulmonary 
arteries (Fig. 1). 
Five months after chemotherapy, with cardiopulmo- 
nary bypass and hypothermia (28 ° C), complete resec- 
tion of the tumor was performed. The tumor almost 
completely blocked the lumen of the pulmonary artery 
and invaded into the anterior wall of the pulmonary 
artery. In addition, the tumor originated from the 
pulmonary valve proximally, could not be separated 
from the anulus, and extended istally into both pul- 
monary arteries. The pulmonary artery was resected 
beyond the bifurcation, including the valve and parts of 
the anterior right ventricular outflow tract, and re- 
placed with a cryopreserved valved bifurcation ho- 
mografl (Bioimplant Services Foundation, Eurotrans- 
plant, Leiden, The Netherlands). The prosthetic valve 
was placed proximally in the previous plane of the 
pulmonary valve. The partially resected outflow tract of 
the ventricle was reconstructed with autologous peri- 
cardium. Tumor extending into the arteries was re- 
sected as in a pulmonary thromboendarterectomy. His- 
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Table I. Review of patients treated surgically in the past 10 years 
Status and (months between 
Authors, year Location Metastases Therapy therapy and status) 
de Smet et al., 8 1986 PA No 
Krfiger et al., 2 19901 PA Lung 
Nehrlich et al., 9 1990 PA Lung, adrenal glands 
Iversen et al., 4 19913 PA No 
PA No 
Head et al., 5 1992 PA No 
Berney et al., 1° 1992 PV No 
Johansson et al., 11 1994 PA Mediastinum 
Tanaka et al., 3 1994 PA Lung 
Kawamura et al., ~2 1994 PA Lung 
Current case report, 1996 PA Lung 
Resection Dead, 0 
Resection Dead, 7 
Resection Dead, 2 
Resection, chemotherapy, Dead, 18 
radiation 
Resection Alive, 3 
Resection, chemotherapy, Alive, 36 
radiation 
Resection Alive, 11 
Resection Died at operation 
Resection Dead, 8 
Resection Dead, 10 
Neoadjuvant chemother- Alive, 20 
apy, resection 
PA, Pulmonary artery; PV,, pulmonary vein. 
tologic examination of the resected-specimen showed 
no viable tumor tissue. After 17 days, the patient was 
discharged and was feeling well. At follow-up examina- 
tion 12 months after the operation, the patient was alive 
and well without any evidence of recurrence. 
Favorable prognosis of primary pulmonary sarcoma 
depends on early diagnosis. The symptoms are nonspe- 
cific; the cause for admission is often a suspicion of a 
pulmonary embolism. Sixty percent 2 of pulmonary sar- 
comas are diagnosed at postmortem examination, but 
this is happening with decreasing frequency as a result 
of newer therapy in the past decade. Currently, surgical 
resection remains the therapy of choice (Table I). The 
vast majority of the patients in reported cases (70%) 
were operated upon with the presumed iagnosis of 
thromboembolism. Simple resection of the tumor with- 
out prosthesis or graft substitution is the most frequent 
operation performed. Resection is often incomplete 
(ratio 1:2) because of the advanced stage of the tumor. 
Only a few cases of alloplastic 3'4 or homograft 5'6 
replacement have been reported. Precise preoperative 
planning with echographic measurements of the pulmo- 
nary valve, pulmonary artery, and branch pulmonary 
arteries is desirable when doing elective replacement. 
Adjuvant radiotherapy, chemotherapy, or a combina- 
tion of both 4' s have so far been carried out only after 
tumor resection. To our knowledge, multimodal treat- 
ment with chemotherapy aspretreatment before oper- 
ation, such as was used in our case, has not been 
reported. The prognosis is extremely poor. Only 10% of 
the patients urvive longer than 1 year after diagnosis. 7 
The mean survival of patients with primary resection 
(10 months) is significantly onger than that of patients 
without resection. 2 Adjuvant radiotherapy, chemother- 
apy, and combinations are not regarded as effective by 
some despite significantly onger survival 2 because sur- 
vival after the third postoperative y ar is similar to that 
of patients who have not received adjuvant treatment. 
Table I, however, shows that patients who undergo 
combined therapy 4'5 appear to have the longest sur- 
vival. When multiple metastases are present, as in our 
case, chemotherapy after complete or partial remission 
may allow resection. 6 
These data suggest hat after a chemotherapeutic re-
sponse extensive resection and reconstructive surgery is 
justified in patients with pulmonary sarcoma. 
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SALVAGE RESECTION OF A CHEMOREFRACTORY MEDIASTINAL GERM CELL TUMOR 
Michel Rivoire, MD, PhD, a Eric Voiglio, MD, a Pierre Kaemmerlen, MD, b Isabelle Treilleux, MD, c Pierre Biron, MD, d 
and Jean Pierre Droz, MD, d Lyon, France 
Primary mediastinal nonseminomatous germ cell tu- 
mors are uncommon, accounting for only 1% to 3.5% of 
all tumors of the mediastinum and 1% to 2% of all germ 
cell tumors in male patients. 1 Outcome for these tumors 
has improved considerably with the combination of cispla- 
tin-based chemotherapy followed by aggressive opera- 
tion. 2 Nevertheless, 50% to 60% of cases are not cured by 
this multimodal approach; almost all patients who have 
only partial response status without return to normal 
serum levels of tumor marker and those who have relapses 
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with elevated levels of tumor marker die, even when 
treated with high-dose chemotherapy and hematopoietic 
stem-cell support. Salvage resection of chemorefractory 
germ cell tumors of the testis was recently reported to 
result in a cure rate of 50% in one patient population. 3 
Salvage resection of mediastinal germ cell tumors has not 
yet been reported. We describe the case of a patient with 
a chemorefractory primary mediastinal germ cell tumor in 
whom a series of operations resulted in sustained, com- 
plete remission. 
A 30-year-old man was referred to our hospital in 
February 1992 for a histologically confirmed pure primary 
choriocarcinoma of the anterosuperior mediastinum with 
widespread lung metastases (Fig. 1). Ultrasonography 
showed both testes to be normal. No other metastatic sites 
were detected with whole-body computed tomographic 
scan. The initial serum level of human chorionic gonado- 
trophin hormone (hCG) was 80,000 mIU/ml (normal <4 
Fig. 1. Chest computed tomographic scan showing tumor of anterosuperior mediastinum with bilateral 
lung metastases. 
